We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

GlaxoSmithKline (Ireland) Ltd

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 495 5000
Fax: +353 1 4955225
Medical Information Direct Line: 1 800 244 255
Medical Information Facsimile: +353 1 495 5225
Patient Information Leaflet last updated on medicines.ie: 06/06/2017
PIL Augmentin Paediatric 125mg/31.25mg per 5ml Powder for Oral Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 06/06/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 23/12/2015 and displayed until 06/06/2017
Reasons for adding or updating:
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 16/07/2015 and displayed until 23/12/2015
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 08/04/2015 and displayed until 16/07/2015
Reasons for adding or updating:
  • Change of contraindications
  • Change to storage instructions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to further information section
  • Change to date of revision
  • Addition of information on reporting a side effect.
Updated on 11/02/2014 and displayed until 08/04/2015
Reasons for adding or updating:
  • Change to, or new use for medicine
Updated on 23/12/2013 and displayed until 11/02/2014
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/08/2012 and displayed until 23/12/2013
Reasons for adding or updating:
  • Change to further information section
Updated on 02/11/2010 and displayed until 16/08/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL
  • Change due to user-testing of patient information
Updated on 24/02/2010 and displayed until 02/11/2010
Reasons for adding or updating:
  • Change of trade or active ingredient name
  • Change of inactive ingredient
  • Change to storage instructions
Updated on 26/10/2006 and displayed until 24/02/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/05/2005 and displayed until 26/10/2006
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Amoxicillin trihydrate
   Potassium clavulanate